Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
AMGN has been in the news recently: Amgen Inc. is involved in a lawsuit against HHS Secretary Robert F. Kennedy Jr. over a drug discount program issue, along with Eli Lilly and Co. and UCB SA. Despite reporting second-quarter results that surpassed analyst expectations, Amgen Inc. shares experienced a decline following the announcement.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
